Marksans Pharma has received USFDA approval for Paricalcitol capsules which are used for treating hyper parathyroidism. The Paricalcitol capsules are therapeutically equivalent to the reference listed drug Zemplar Capsules 1 mcg, 2 mcg and 4 mcg and Vitamin D is important for absorption of calcium from the stomach and for functioning of calcium in the body.
Company Profile : Marksans Pharma Ltd
Leave a Reply